Poster Programme 2010

To see the 2010 Abstracts click here

Clinical Abstract Posters 2010

	AKI 1 (Tuesday 18^th May 12.00-13.00)
P41	The incidence of acute kidney injury referred for a renal opinion in a large teaching hospital without an onsite renal unit Gopaluni, Seerapani, St.Jame’s University Hospital, Leeds
P42	Emergency transfer of in-patients to renal services – admission MEWS scoring may identify those at risk of needing early critical care Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P43	Diagnosis and management of Acute Kidney Injury (AKI): deficiencies in the knowledge base of non-specialist, junior medical staff Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P44	Key bedside assessments in Acute Kidney Injury (AKI): deficiencies in the knowledge base of non-specialist, nursing staff Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P45	Acute Kidney Injury is common in adults and associated with a high mortality Quinn, Michael P, Regional Nephrology Unit
P46	Outcome data for a UK renal ward-based high dependency unit Sharpe, Claire, King's College London

	AKI 2 (Tuesday 18^th May 12.00-13.00)

P109	Standard Equations that Estimate GFR do not Accurately Predict Creatinine Clearance in Critically Ill Patients with Acute Kidney Injury Kirwan, Christopher, St George's, University of London
P110	Contrast induced nephropathy in patients admitted for a CTPA Mohteshamzadeh, Mobin, Royal Berkshire NHS Foundation Trust
P111	Pandemic Influenza A: H1N1 and renal failure: The experience of the Irish national tertiary referral centre O’Brien, Frank, Beaumont Hospital
P112	Validation of urinary biomarkers to identify risk of acute kidney injury after coronary artery bypass surgery – a pilot study Ravanan, Rommel, Southmead Hospital
P113	Towards a useful prognostic score for acute kidney injury (AKI): a one year survival study in one UK centre Thomas, Mark, Heart of England NHS Foundation Trust

	AKI 3 (Wednesday 19^th May 12.30-13.30)

P47	RIFLE, AKIN and time-independent creatinine change criteria identify different patients at risk of acute kidney injury Garner, Ashley, Leeds Teaching Hospitals NHS Trust
P48	When to start haemodialysis in native versus transplant renal failure; an observational single centre, retrospective study Imran, Muhammad, Royal Liverpool University Hospital NHS Trust
P49	Ward-based consultant nephrologists and introduction of a modified early warning system (MEWS) may improve intensive care outcomes in in-patients transferred from a regional renal Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P50	Fluids for continuous renal replacement therapy (CRRT) – an evaluation of microbial integrity. Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P51	How can we improve the management of Acute Kidney Injury: data from a teaching hospital setting Pal, Soubhik, Sheffield Kidney Institute
P52	Pharmacological Therapies for the Prevention of Acute Kidney Injury Following Cardiac Surgery: A Systematic Review. Patel, Nishith, University of Bristol

	AKI 4 (Thursday 20^th May 11.30-12.30)

P104	Urinary and plasma NGAL levels reflect the severity of acute kidney injury Bangert, Kristian, BioPorto, A/S, Denmark
P105	Early reductions in serum immunoglobulin free light chains (FLC) predict renal recovery in myeloma kidney and dialysis-dependent AKI. Hutchison, Colin, University of Birmingham
P106	Real-time biochemical diagnosis of Acute Kidney Injury: definitions and alert thresholds for an electronic decision support system Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P107	The Presence of an Allele Which Codes for Functional CYP3A5 Reduces the Effect of AKI on Hepatic Midazolam Metabolism in Critically Ill Patients Kirwan, Christopher, St George's, University of London
P108	Hepatic Metabolism of Midazolam is Inhibited in Critically Ill Patients with Acute Kidney Injury Kirwan, Christopher, St George's, University of London

	Anaemia (1) (Wednesday 19^th May 12.30-13.30)

P157	ESA Prescribing by Pharmacist: Conversion from short acting to a long acting ESA and maintenance of Hb in target range in haemodialysis patients Baig, Israr, Glocestershire Hospitals NHS Foundation Trust
P158	Switching from a subcutaneous Erythropoiesis Stimulating Agent (ESA) preparation to intravenous darbepoetin alpha (Aranesp) improves Haemoglobin without increasing ESA requirement in haemodialysis patients Imedi, Asia, The Royal London Hospital, Whitechapel
P159	Reduction of Erythropoesis Stimulating Agent requirements when converting patients from Epoetin beta (Neorecormon) and Darbepoetin alpha (Aranesp) to Mircera in haemodialysis Popat, Reena Royal London Hospital, Whitechapel
P160	The Impact of Switching ESA therapies in the non dialysis population - a single centre experience Sherwood, Amanda, East Kent Hospitals University NHS Foundation Trust
P161	18 month experience in managing stable haemodialysis patient cohorts with Methoxy polyethylene glycol-epoetin beta (Micera) Suckling, Rebecca, Guy's and St. Thomas's Hospital
P162	Switching from Aranesp to Eprex in Haemodialysis: 18 Months of Follow-Up Todd, Matt, Wessex Renal & Transplant Unit

	Anaemia (2) (Wednesday 19^th May 12.30-13.30)

P168	Evaluation of an ESA Dose Adjustment Algorithm Designed to Reduce Haemoglobin Cycling in Haemodialysis Patients. Lindley, Elizabeth, Leeds Teaching Hospitals NHS Trust
P169	Audit of the effectiveness of new intravenous iron therapy for the treatment of anaemia in CKD patients Malik, Shafi, Wrexham Maelor Hospital, North Wales
P170	Efficacy and Safety of a single dose of Ferric Carboxymaltose in the treatment of iron deficiency anaemia in patients not on dialysis with Chronic Kidney Disease McDaid, Dianne, HSE West Ireland
P171	Repatriation of ESA prescribing and administration in haemodialysis patients reduces cost without affecting the efficacy of erythropoiesis response Popat, Reena, Royal London Hospital, Whitechapel
P172	The Dispersion of Haemoglobin Values is associated with Renal Anaemia Management Strategies within Haemodialysis Units and the Risk of Mortality: data from the DOPPS Will, Eric, NHS

	Anaemia (3) (Thursday 20^th May 11.30-12.30)

P163	Erythropoietin therapy does not ameliorate tubular injury in advanced diabetic nephropathy Singh, Dhruv, Lister Hospital
P164	Use of a new tandem mass spectrometry assay to measure serum hepcidin: a comparison of levels in haemodialysis patients with healthy controls and patients with hereditary haemochromatosis. Brincat, Stephan, King's College Hospital, London
P165	The Prevalence and causes of Anaemia in Type 2 Diabetics with stage 3 Chronic Kidney Disease Raja, Umar Yousaf, Birmingham Heartlands Hospital
P166	Hb response to erythropoietin in chronic kidney disease patients with myelodysplastic syndromes Raza, Muhammad, Gloucestershire Royal Hospital
P167	Plasma hepcidin may predict the haemoglobin response to intravenous iron in haemodialysis patients Ashby, Damien, Imperial College

	Cardiovascular Disease 1 (Thursday 20^th May 11.30-12.30)

P185	Subjective Global Assessment is an independent predictor of cardiac ischaemia in patients with mild CKD Aldous, Georgina, Imperial Healthcare NHS Trust
P186	Does ethnicity and gender influence severity of coronary artery disease and cardiac survival in potential renal transplant recipients undergoing coronary angiography? Kumar, Nicky, West London Renal & Transplant Centre
P187	Proteinuria is significantly associated with left ventricular mass index in patients with chronic kidney disease. McQuarrie, Emily, BHFGCRC, University of Glasgow
P188	Long term cardiovascular survival in ESRD patients undergoing screening for renal transplantation: a cardiac MRI study. Patel, Rajan, Renal Research Group, BHFGCRC, University of Glasgow
P189	Intracranial carotid artery calcification and ischaemic stroke in haemodialysis Power, Albert, Imperial College Kidney & Transplant Institute

	Cardiovascular Disease 2 (Tuesday 18^th May 12.00-13.00)

P179	Prediction of renal functional outcome after revascularization with magnetic resonance imaging in atherosclerotic renovascular disease Chrysochou, Constantina, University of Manchester
P180	Effects of renal impairment on clinical presentation among those with malignant hypertension: Results from an existing registry at City Hospital, Birmingham. Dasgupta, Tanaji, Churchill Hospital
P181	Urinary proteomic diagnosis of coronary artery disease Delles, Christian, University of Glasgow
P182	Targeted control of blood pressure in paediatric renal transplant recipients Dolan, Niamh, Great Ormond Street Hospital for Children NHS Trust
P183	Serum Angiopoietin 2 levels are associated with Increased Mortality in CKD patients John, Stephen, Royal Derby Hospital
P184	Endotoxaemia in Older People with CKD is Attenuated by Anti-hypertensive Drug Therapy John,Stephen, Royal Derby Hospital

	CKD (1) (Wednesday 19^th May 12.30-13.30)

P152	A study of the natural history of Diabetic Kidney Disease (DKD) Altemtam, Nagi, Sheffield University
P153	Repeat testing significantly reduces the estimated prevalence of chronic kidney disease and identifies a population with increased cardiovascular risk Brook, Matthew, Oxford Kidney Unit
P154	Prevalence of Chronic Kidney Disease of African Caribbeans in the UK: the KEEP UK study Jurawan, Nerissa, University Hospitals Birmingham NHS Foundation Trust
P155	Prevalence of Chronic Kidney Disease in the Relatives of patients with kidney disease in the UK: the KEEP UK Study Jurawan, Nerissa, University Hospitals Birmingham NHS Foundation Trust
P156	Predictors of Chronic Kidney Disease recording on disease registers in primary care: a cross-sectional survey of GP practices and their performance in the Quality Outcome Framework Walker, Nicola, University of Leicester

	CKD (2) (Wednesday 19^th May 12.30-13.30)

P141	Chronic Kidney Disease influences important life changing decisions over time Bhatti, Zaheer Uddin, University Hospital of Wales, Cardiff
P142	Can stage 3 CKD patients attending hospital clinics be safely discharged to primary care? Blow, Rebecca, Heartlands Hospital
P143	The economic implications of improvement in blood pressure control in Primary Care driven by the Renal Quality Outcomes Framework (QOF) indicators. Irving, Jean, Kent Kidney Care Centre
P144	Pick our brains - how an e-mail helpline helps Primary Care cope with the CKD mountain Main, John, James Cook University Hospital, Middlesbrough
P145	‘NICE’ CKD guidelines can help in improving efficiency and appropriate use of specialist nephrology services in the management of patients with CKD: a study based on an audit in patients referred to an outreach renal clinic Sammut, Hannah, Royal Liverpool University Hospital
P146	Success of the Quality and Outcome Framework (QOF) in capturing known Chronic Kidney Disease (CKD) in Primary Care Shields, Joanne, Centre for Public Health

	CKD (3) (Wednesday 19^th May 12.30-13.30)

P129	Risk factors for developing chronic kidney disease in patients with essential hypertension – where else can we look? Dreyer, Gavin, Royal London Hospital
P130	Compliance with Renal Association phosphate audit standards: comparing prevalent dialysis patients with 4,054 pre-dialysis patients on the UK Renal Registry database Ford, Daniel, UK Renal Registry
P131	How safe is ACE and ARB therapy after successful renal arterial intervention in Atherosclerotic Renal Artery Stenosis (ARAS)? Goldsmith, David, Guy's & St. Thomas’ NHS Foundation Trust
P132	Trends in Non-Steroidal Anti-Inflammatory Prescribing in Chronic Kidney Disease Hill, Christopher, Belfast City Hospital
P133	Prevalence of Primary Hyperparathyroidism in Chronic Kidney Disease Hinchliffe, William, Newcastle-upon-Tyne NHS Foundation Trust
P134	Are Obese Patients with Hypertension More Likely to Have Renal Impairment? Jesky, Mark, Heartlands Hospital

	CKD (4) (Wednesday 19^th May 12.30-13.30)

P120	Mortality of Patients with Stage 4 and 5 Chronic Kidney Disease in Edinburgh Duthie, Fiona, Royal Infirmary of Edinburgh
P121	Late referral for dialysis in S.E Wales: missed opportunities Lodhi, Vikas, Institute of Nephrology
P122	Determinants of Skin Autofluresence in CKD Stage 3 patients McIntyre, Natasha, Department of Renal Medicine
P123	Do Death Certificates Mention Kidney Failure Shields, Joanne, Centre for Public Health

	CKD (5) (Thursday 20^th May 11.30-12.30)

P147	Functional Course of CKD: A Prospective Cohort Study from Inception of Nephrology Care Hoefield, Richard, Salford Royal Foundation NHS Trust
P148	Polyclonal immunoglobulin free light chains predict patient survival and renal decline in Chronic Kidney Disease. Hutchison, Colin, University of Birmingham
P149	Abnormalities of the opg/rankl axis in progressive kidney failure: the variable influence of diabetes Singh, Dhruv, Lister Hospital
P150	The prevalence of androgen deficiency in male patients with advanced CKD – an evaluation in pre-dialysis and haemodialysis populations Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P151	Prediction of ESRD: an accelerated deterioration in renal function is a frequent occurrence in pre-dialysis patients and may not be associated with a clinical event. Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust

	CKD (6) (Thursday 20^th May 11.30-12.30)

P135	Low Risk of Nephrogenic Systemic Fibrosis in non dialysis Chronic Kidney Disease patients investigated with gadolinium-enhanced magnetic resonance imaging Chrysochou, Constantina, Salford Royal Hospital
P136	A retrospective study of the effect of biliopancreatic diversion for weight loss on renal function Dasgupta, Indranil, Birmingham Heartlands Hospital
P137	Chronic kidney disease in lithium-treated patients: a survey of case notes Impey, Matthew, Rotherham, Doncaster and South Humber NHS trust
P138	Systemic inflammation in chronic kidney disease: effect of acute and regular moderate intensity aerobic exercise Viana, Joao, Loughborough University
P139	‘Hypokalaemic nephropathy’ in Gitelman’s and Bartter’s syndromes: Does it occur? Walsh, Stephen Royal Free Hospital
P140	Early renal impairment is an independent predictor of vascular calcification in type 2 diabetes Singh, Dhruv, Lister Hospital

	CKD (7) (Thursday 20^th May 11.30-12.30)

P124	An elevated triglyceride:HDL-C ratio is strongly associated with chronic kidney damage - proteinuria and an eGFR < 60 ml/min/1.73 m2. Davies, Joseph, King's College London
P125	Getting evidence into practice in the management of chronic kidney disease: the collaboration for leadership in applied health research and care (CLAHRC) for greater Manchester Gwozdziewicz, Maciej, CLAHRC for Greater Manchester
P126	Working In Partnership With Primary Care To Empower Patients With Chronic Kidney Disease (CKD). Jain, Neerja, Kidney Research UK
P127	Chronic kidney disease (CKD) and hospitalization in older people: results from the MRC Assessment Study Nonyane, Bareng Aletta, London School of Hygiene and Tropical Medicine
P128	Designing ‘patient centred care’ for Cystinurics: the experience of a new specialist multi-disciplinary clinic. Thomas, Kay, Guy’s and St. Thomas' NHS Foundation Trust

	CKD (8) (Thursday 20^th May 11.30-12.30)

P114	Measurement for Improvement Barclay, Anna, NIHR CLAHRC for Greater Manchester
P115	Development of Guidelines for the Management of Non-Visible Haematuria de Takats, Dominic, University Hospital of North Staffordshire
P116	Age and gender comparisons between patients commencing RRT and 1,854 patients reaching stage 5 CKD at 6 UK renal centres Ford, Daniel, UK Renal Registry
P117	Estimation of ESRD by extrapolation of the reciprocal creatinine trend is subject to clinician variability Kanagasundaram, Nigel, Newcastle upon Tyne Hospitals NHS Foundation Trust
P118	Chronic kidney disease (CKD) management in primary care: appropriate discharge from nephrology services and adequate monitoring post-discharge. Meran, Soma, Cardiff and Vale NHS Trust
P119	How tall are your kidneys – what is the best ultrasound measure of renal size in chronic kidney disease (CKD)? Thomas, Mark, Heart of England Foundation Trust

	Conservative & Palliative Care (Wednesday 19^th May 12.30-13.30)

P22	Long Term Outcome in Conservative management of Advanced Chronic Kidney Disease Chandna, Shahid, Lister Hospital
P23	Integrating Palliative Care within a Low Clearance Clinic is Associated with Improved Outcomes Mooney, Andrew, Leeds Teaching Hospitals NHS Trust
P24	The experience of withdrawing from dialysis: perceptions of bereaved carers Murphy, Emma, Kings College London
P25	Attitudes of renal unit staff towards advance planning of end of life care for dialysis patients Nagaraja, Pramod, University Hospital of Wales
P26	Quality of End of Life Management: Results from the Pan-Thames Renal Audit Group Salisbury, Emma, Imperial College London
P27	Use of the Liverpool End of Life Care Pathway and Symptom Management in Patients Dying with Advanced Chronic Kidney Disease Wenham, Sarah, Salford Royal NHS Foundation Trust

	GN (1) (Tuesday 18^th May 12.00-13.00)

P242	Safety and Efficacy of Rituximab in steroid dependent and steroid resistant nephrotic syndrome in children and young adults Koziell, Ania, Department of Paediatric Nephrology
P243	Tacrolimus is an effective and safe treatment of de novo Minimal Change Glomerulonephritis in adults. Lawrence, Christopher, Imperial Kidney and Transplant Institute
P244	Outcome of idiopathic membranous nephropathy and nephrotic syndrome in the modern era McQuarrie, Emily, Western Infirmary, Glasgow
P245	Outcome of Anti GBM disease in West Sector Greater Manchester Ponnusamy, Arvind, Salford Royal NHS Foundation Trust
P246	Rituximab as primary therapy in glomerular basement membrane antibody disease- case series. Shah, Yaser, Arrowe Park Hospital
P247	Have changes in the management of patients with primary focal segmental glomerulosclerosis (FSGS) over a seventeen year period improved overall renal survival Xu, Gang University Hospitals of Leicester

	GN (2) (Thursday 20^th May 11.30-12.30)

P259	PEXIVAS: Design of a Randomised Controlled Trial of Plasma Exchange and Glucocorticoid Dosing in Severe ANCA Associated Vasculitis Casian, Alina, Addenbrooke's Hospital
P260	Use of simple pathological measurements may help predict kidney survival in patients with pauci-immune necrotizing glomerulonephritis presenting with severe kidney dysfunction Day, Clara, Queen Elizabeth Hospital, Birmingham
P261	Mycophenolate Mofetil Induction Therapy for ANCA-Associated Systemic Vasculitis. Jones, Rachel, Addenbrooke's Hospital NHS Trust
P262	Henoch-Schönlein Purpura in Adults: A Single Centre Review Ponnusamy, Arvind, Salford Royal NHS Foundation Trust
P263	The Changing Ethnic Prevalence of ANCA associated Vasculitis in London:Increasing Indo-Asian influence with critical differences in disease outcome Tanna, Anisha, Imperial College NHS Trust

	GN 3 (Thursday 20^th May 11.30-12.30)

P248	Retrospective study of treatment and outcomes in patients presenting with anti-gbm disease 2000-2010 Borman, Natalie, Wessex Renal unit
P249	Treatment of lupus nephritis with Rituximab & Mycophenolate mofetil (MMF) but without oral steroids leads to high rates of maintained remission & low relapse rates Condon, Marie, Kidney & Transplant Institute
P250	Tacrolimus is an Effective and Safe Agent in Resistant Lupus Nephritis Condon, Marie, West Imperial College Kidney & Transplant Institute
P251	Mycophenolate mofetil treatment in paediatric onset systemic lupus erythematosus Kazyra, Ina, Belarus State Medical University

	GN 4 (Wednesday 19^th May 12.30-13.30)

P264	Delay to administration of cyclophosphamide in ANCA associated vasculitis affects renal survival Brown, Nina, Royal Liverpool Hospital
P265	PR3-ANCA positivity in patients without primary systemic vasculitis McAdoo, Stephen, Imperial College London
P266	Pauci-immune Glomerulonephritis in Royal Preston Hospital July 2005 to September 2008 Ogundare, Olumide, Manchester Royal Infirmary
P267	Azathioprine: dosing and complications in pauci-immune renal vasculitis Stevens, Kathryn, Glasgow Royal Infirmary
P268	Plasma exchange for renal vasculitis: a meta-analysis Walsh, Michael, McMaster University, Ontario, Canada

	HD Miscellaneous (Wednesday 19^th May 12.30-13.30)

P310	A Cross-sectional Study of Radiological Prevalence and Morbidity associated with ß2-microglobulin Amyloidosis in a Chronic Haemodialysis Population Ferenbach, David, University of Edinburgh
P311	Self-care, improving productivity and quality Hatton, Cathy, Heart of England NHS Foundation Trust
P312	Failure to remove immunoglobulin free light chains by high cut-off haemodialysis Hutchison, Colin, University Hospital Birmingham
P313	Differential accuracy of alternative methods for blood gas sampling during haemodialysis Odudu, Aghogho, Derby Hospitals NHS Foundation Trust
P314	Prescribing dialysis fluid - associations between haemodialysate potassium concentration and mortality Rayner, Hugh, Heart of England NHS FT
P315	Use of heparin-coated AN69 ST membrane (Nephral) in patients with or at high risk of bleeding on haemodialysis and haemodiafiltration Shah, Yaser, Arrowe Park Hospital

	HD: Access (Tuesday 18^th May 12.00-13.00)

P321	Button-Hole V Rope Ladder (One Year On) Allen, Clive, Heart of England NHS Foundation Trust
P322	Access All Areas: What is the primary patency rate of our new arteriovenous fistulae and grafts? Berry, Miriam, Norfolk and Norwich University Hospital
P323	The Development and Outcomes of a Nurse-Led Haemodialysis Catheter Insertion Service Brylka-Mee, Nick, Leicester General Hospital
P324	Semi-blunt needles for buttonhole cannulation in arterio-venous fistulas: is outcome better? Goovaerts, Tony, Université Catholique de Louvain, Brussels, Belgium.
P325	Percutaneous Transluminal Angioplasty in the Treatment of Dysfunctional Arteriovenous Fistulae Jurawan, Nerissa, University Hospital Birmingham Nhs Foundation Trus
P326	Fistula and graft thrombolysis: a retrospective review of 2 years' experience Smith, Rona, Norfolk and Norwich University Hospitals

	HD: Cardiovascular (1) (Tuesday 18^th May 12.00-13.00)

P339	Low Prevalence of Cardiovascular Disease in Long-term Survivors on Dialysis Bisset, Linda , Derby Hospitals NHS Foundation Trust
P340	ADMA and Endotoxaemia A Newly Recognised Potential Link in the Inflammatory Pathways of Chronic Kidney Disease and Dialysis Eldehni, Mohamed Tarek, Derby Hospitals NHS Foundation Trust
P341	Central Venous Oxygen Saturation: A potential new marker for circulatory stress in haemodialysis patients. Harrison, Laura Derby Hospitals NHS Foundation Trust
P342	Endotoxinaemia in haemodialysis patients is not associated with excessive hydration Harrison, Laura, Derby Hospitals NHS Foundation Trust
P343	Valvular Calcification in Patients with End-Stage Kidney Disease on Maintenance Haemodialysis Spyropoulos, Achillefs, Heart of England NHS Foundation Trust
P344	Can Serial Bioelectrical Impedance Vector Analysis Improve the Management of Paediatric Dialysis Patients? Tyerman, Kay, Leeds Teaching Hospitals NHS Trust

	HD: Cardiovascular (2) (Wednesday 19^th May 12.30-13.30)

P345	Is N terminal probrain type natriuretic peptide a marker of cardiac dysfunction, fluid overload or malnutrition in haemodialysis patients? Booth, John, Royal Free Hospital
P346	Potentially Pathogenic Circulating Cardiac Troponin Autoantibodies are Present in Haemodialysis Patients Jefferies, Helen, Derby Hospitals NHS Foundation Trust
P347	Intradialytic Hypotension: Moving towards the individualised haemodialysis prescription Meredith, David, Oxford Kidney Unit
P348	A bioimpedance study assessing the relationship between inflammation and body composition in a haemodialysis population. Prabhavalkar, Siddhesh, Altnagelvin Hospital, Londonderry
P349	Relationship of Physical Activity with Metabolic Rate in End-Stage Renal Failure Vilar, Enric, Renal Research Lab, Lister Hospital, Stevenage
P350	Biometric Predictors of Resting Energy Expenditure in End-Stage Renal Failure Vilar, Enric, Renal Research Lab, Lister Hospital, Stevenage

	HD: Home Therapy (Thursday 20^th May 11.30-12.30)

P305	Improving the uptake of home haemodialysis Brady, Mark, Department of Health
P306	Audit of patients awareness and suitability for home haemodialysis Mills, Samantha, Hull and East Yorkshire Hospital Trust
P307	The value of continued education for patients: Home Haemodialysis Retraining Days Smith, Karen, Community Renal Team, Derby Hospitals NHS Foundation Trust
P308	Improving the pathway for home haemodialysis: a single centre experience Swan, Christopher, Derby Hospitals NHS Foundation Trust
P309	Listening to patients' voices to help improve access to home haemodialysis Taylor, Francesca, NHS Kidney Care

	HD: Infection (Thursday 20^th May 11.30-12.30)

P316	What are the non-infectious risks associated with haemodialysis away from centre? Corbett, Robert, Imperial College Kidney and Transplant Institute
P317	What are the infection risks associated with haemodialysis while away from the home centre? Prout, Virginia Imperial College Kidney and Transplant Institute
P318	Vancomycin and gentamicin based antibiotic line lock is cost effective and reduces catheter related sepsis and thrombosis Mohiuddin, Syed, Royal Liverpool Hospital
P319	Hepatitis C transmission via haemodialysis machines Thomson, Peter, Glasgow Royal Infirmary Renal Unit
P320	High risk of contracting Hepatitis C for patients from the UK during holiday haemodialysis outside of the UK Veighey, Kristin, West London Renal and Transplant Centre

	HD: Management (Wednesday 19^th May 12.30-13.30)

P327	Medical assessment of haemodialysis patients in Libya Alashek, Wiam, University of Nottingham Medical School at Derby
P328	Characteristics of dialysis services in Libya Alashek, Wiam, University of Nottingham Medical School in Derby
P329	The Integration of an Assistant Practitioner into the Vascular Access Team. Daniel, Simon, North Bristol NHS Trust
P330	Clinical Management of Patients During Their Transition from Failed Renal Transplant to Dialysis. Imran, Muhammad, Royal Liverpool University Hospital NHS Trust
P331	Issues important to patients on haemodialysis: patient vs medical Prospective Leung, Janson, Derby Hospitals NHS Foundation Trust
P332	Specialised foot care of the haemodialysis patient by podiatry is inadequate despite a high prevalence of lower limb amputation. Pollard, Hazel, Lancashire Teaching Hospitals

	HD: Sodium (Thursday 20^th May 11.30-12.30)

P333	Correct calibration of delivered sodium dialysate concentration results in improved blood pressure control. Edwards, Claire, Imperial College Healthcare NHS Trust
P334	The effect of isovolemic dialysis and alterations in dialysate sodium on segmental ECF resistance measured by Continuous Segmental Bioimpedance Analysis (CSBA) Mathavakkannan, Suresh, Lister Hospital
P335	Negative sodium gradients are associated with greater sodium removal without adversely affecting inter-dialytic weight gain: Support for an individualisation of dialysate sodium Odudu, Aghogho, Derby Hospitals NHS Foundation Trust
P336	Study of sodium kinetics by conductivity monitoring in haemodialysis Odudu, Aghogho, Derby Hospitals NHS Foundation Trust
P337	Impact of lower sodium exposure on symptoms in haemodialysis Power, Albert, Imperial College Kidney & Transplant Institute
P338	Atrial Natriuretic Peptide and its relationship to total body water in haemodialysis patients Sivalingam, Murugan, Lister Hospital

	HD: Survival (Tuesday 18^th May 12.00-13.00)

P351	Relationship between dialysis schedule and day-of-week association with mortality in the DOPPS Greenwood, Roger, Lister Hospital
P352	Dialysis in the over 80 year olds: Who are they and how do they fare? Isaacs, Anthony, Royal Free Hospital
P353	Black ethnicity predicts better survival on RRT despite greater deprivation and diabetes. Jones, Chris, Renal Unit
P354	Exposure to Ionising Radiation in Haemodialysis patients. Kinsella, Sinead, Cork University Hospital
P355	Monitoring of vital signs during haemodialysis sessions. Meredith, David, Oxford Kidney Unit, Churchill Hospital,
P356	Prognosis of elderly patients on haemodialysis – a novel comorbidity score Power, Albert, Imperial College Kidney & Transplant Institute

	Medicines Management (Thursday 20^th May 11.30-12.30)

P173	Audit of General Practitioners recording of hospital initiated renal medication Hunter, Katy, North Bristol NHS Trust
P174	How safe and useful is tiopronin in the treatment of cystinuria? Moochhala, Shabbir, Freeman Hospital, Newcastle upon Tyne
P175	An Education Programme for Health Care Assistants for the Administration of Medicines in a Haemodialysis Unit Parsons, Valerie, East Kent Hospitals University NHS Foundation Trust
P176	Accurate comprehensive costing of medications prescribed for haemodialysis patients Roche, Fiona, Western Health & Social Care Trust
P177	The implementation of a pharmacist led hepatitis B vaccination programme Shaw, Susan, Derby Hospitals NHS Foundation Trust
P178	A drug chart renal impairment sticker optimises appropriate prescribing practice in patients with renal failure Webster, Philip, Heatherwood & Wexham Park NHS Trust

	Miscellaneous 1 (Tuesday 18^th May 12.00-13.00)

P190	Urinary biomarkers in HIV infected patients: does black ethnicity protect against tubular dysfunction? Hendry, Bruce, King's College London
P191	AA amyloidosis in injecting drug users Moriarty, Jim North Bristol NHS Trust
P192	Urine C-peptide/creatinine ratio (UCPCR) is not significantly affected by the presence of CKD Oram, Richard, Royal Devon and Exeter NHS Foundation Trust
P193	Urinary C-Peptide/Creatinine Ratio (UCPCR): a better test of insulin production in subjects with type 2 diabetes and renal impairment Oram, Richard, Royal Devon and Exeter NHS Foundation trust
P194	The use of bedside blood ketone measurment in the diagnosis of Diabetic Ketoacidosis in patients with End Stage Renal Failure. Shojai, Parastoo, North Bristol NHS Trust

	Miscellaneous 2 (Tuesday 18^th May 12.00-13.00)

P379	Abolishing acute haemodialysis catheter associated blood stream infections Alderson, Helen, Salford Royal Hospital NHS foundation Trust
P380	Application of a Microdialysis Technique To Study Interstitial “Uremic” Toxins. Ebah, Leonard, Manchester Royal Infirmary
P381	Changes in Serum Phosphate and Renal Function in Patients with Chronic Hepatitis B Virus Infection Treated with Tenofovir or Adefovir O'Riordan, Aisling, King's College Hospital
P382	Continued Success in Reducing MRSA Bacteraemia Powers, Sarah, Heart of England NHS Foundation Trust
P383	Fibrinogen and C3 Depletion in Double Filtration Plasmapheresis Wood, Karen, Sheffield Teaching Hospitals
P384	Long term follow up of renal function post Laparoscopic Nephrectomy Wroe, Caroline, Renal Unit, Sunderland Royal Hospital

	Miscellaneous 3 (Wednesday 19^th May 12.30-13.30)

P252	Developing an education and assessment framework for renal speciality trainees Kamesh, Lavanya UHB Foundation Trust
P253	Mouth Care Assessment Tool for Renal Patients Moreland, Jane Royal Derby Hospital
P254	Day case renal biopsy is safe and effective: outcomes of the largest reported series of day case native renal biopsy Nache, Azri, University Hospitals of Leicester NHS Trust
P255	Does the introduction of a monthly email of dialysis blood results improve haemodialysis patients understanding of their individual blood results? Neil, Jacqueline, University Hospital of North Staffordshire.
P256	Supporting research within the Renal Services multidisciplinary team (MDT) Shaw, Susan, Derby Hospitals NHS Foundation Trust
P257	Patient uptake and usage of online access to renal records (Renal PatientView) Turner, Neil, University of Edinburgh
P258	Decision making about dialysis options may be biased by patient narratives Winterbottom, Anna, University of Leeds

	Miscellaneous 4 (Thursday 20^th May 11.30-12.30)

P195	Heat exchangers in HD machines achieve significant environmental and cost savings Campbell, Fraser, East Kent Hospitals University NHS Foundation Trust
P196	OCT confirmed resolution of macular oedema in a diabetic patient following haemodialysis: A first report Dasgupta, Indranil, Heartlands Hospital
P197	Outcome of biopsy proven Acute Interstitial nephritis-(AIN) - single centre experience from the United Kingdom Fallouh, Bassam, Heartlands Hospital
P198	Percutaneous Intervention for Takayasu Arteritis-Associated Renal Artery Stenosis Hiemstra, Thomas F, University of Cambridge
P199	Report and recommendations from the 1st International Workshop on the Hereditary Amyloidoses and VIIth International Symposium on Familial Amyloidosis. Stangou, Arie, King's College Hospital London, United Kingdom.

	Nutrition: Assessment & Status (1) (Tuesday 18^th May 12.00-13.00)

P28	Audit of the Nutritional status of Low Clearance Clinic Patients reaching End Stage: Where should our nutritional priorities lie? Eddy, Collette, Barts and the London NHS Trust
P29	Nutritional intakes of haemodialysis patients le Roux, Marica, Kent Kidney Care,East Kent Hospitals University NHS Foundation Trust
P30	Nutritional Management of Twin Pregnancy on Maintenance Haemodialysis – A Case Report Lyell, Christel, Central Manchester University Hospital Trust
P31	Nutritional surveillance of haemodialysis patients using anthropometry and a single assessor – a unique role Reynolds, Sarah, East Kent Hospitals University NHS Foundation Trust

	Nutrition: Assessment & Status (2) (Thursday 20^th May 11.30-12.30)

P37	An audit using subjective global assessment of the nutritional status of Stage 4 chronic kidney disease patients Flint, Jan, Royal Free Hampstead NHS trust
P38	Implementation of standards of dietetic care is associated with improved management of high nutritional risk patients in a single centre pre-dialysis clinic MacLaughlin, Helen, King’s College Hospital NHS Foundation Trust
P39	A Comparison of Morbidity Levels in Vegetarian/Vegan vs. Meat-Eating Dialysis Patients Mewton, Tess, Royal Free Hampstead NHS Trust
P40	Reliability of a nutritional screening tool in a single centre haemodialysis population: a pilot study Symes, Fiona, Derby Hospitals NHS Foundation Trust

	Nutrition: Mineral Management (Wednesday 19^th May 12.30-13.30)

P32	‘PHOS GRAPH’ A novel tool for hyperphosphataemia management in haemodialysis patients – a one year study. P Harnett, Southend University Hospital NHS Foundation
P33	Disappointing results with non-calcium based phosphate binders Hunter, Carolyn, Daisy Hill Hospital, Newry
P34	Calcium free phosphate binders: To switch or not to switch Mohteshamzadeh, Mobin, Royal Berkshire NHS Foundation Trust
P35	Removing salt sachets from meal-trays on the ward does not affect patients’ nutritional intake Ward, Jenny, University Hospitals Coventry and Warwickshire NHS Trust
P36	Effect of Changing Calcium Dialysate Concentration on Mineral and Bone Parameters in Satellite Haemodialysis Units Ward, Nicole, Guy's & St Thomas' Foundation Trust

	PD1 (Tuesday 18^th May 12.00-13.00)

P1	Reducing the burden of adequacy measurement: using renal clearance alone to predict weekly total clearance. Brown, Michaela, Scottish Renal Registry
P2	Using a Continuous Quality Improvement (CQI) approach as an agent for change in Peritoneal Dialysis (PD) Denning, Jeanette, Leeds Teaching Hospitals
P3	Symptom burden in older dialysis patients: Data from the BOLDE study Johansson, Lina, Imperial College London
P4	A Pilot Study for the use of Steroid Impregnated Tape in the Treatment of Overgranulation of Peritoneal Dialysis Exit sites. McEntee, Siobhan, University Hospital Birmingham NHS Foundation Trust
P5	An audit cycle demonstrating the value of retraining to reduce the rate of peritonitis within a single centre peritoneal dialysis population Robinson, Gemma, Royal Derby Hospital
P6	Development of a community dialysis support worker role. Community renal team Swainson-Corby, Paige, Community renal team, Derby Hospitals NHS Foundation Trust

	PD2 (Tuesday 18^th May 12.00-13.00)

P13	A Study of Clinical and Genetic Risk Factors for Encapsulating Peritoneal Sclerosis (EPS) – Formally The UK EPS Study and DNA Bank Dunn, Louese, Manchester Royal Infirmary
P14	Characterisation of the natural history of peritoneal dialysis prior to encapsulating peritoneal sclerosis Lambie, Mark, Institute of Science and Technology in Medicine
P15	The histological findings in encapsulating peritoneal sclerosis Mitu-Pretorian, Otilia-Maria, Manchester Royal Infirmary
P16	Residual urine output rather than dialysis adequacy has the most influence on serum vancomycin concentration decline in continuous ambulatory peritonealdialysis Sluman, Christine, Wirral University Teaching Hospital
P17	Reduction of culture-negative peritoneal dialysis peritonitis rates may be achieved by increasing effluent sample volume Sluman, Christine, Wirral University Teaching Hospital
P18	Peritoneal protein leak is dependent on local peritoneal membrane inflammation and co-morbidity but not systemic inflammation in incident peritoneal dialysis patients: a sub-analysis from the GLOBAL Fluid Study Yu, Zanzhe, University Hospital of North Staffordshire

	PD3 (Wednesday 19^th May 12.30-13.30)

P7	Nurse performed LA Peritoneal Dialysis catheter insertions Bowes, Elaine, King’s College Hospital NHS Foundation Trust
P8	Biompedance Assisted Fluid Management Optimises Blood Pressure Control. Burke, Sinead, The Royal London Hospital
P9	Acute peritoneal dialysis in patients presenting with unpredicted end stage renal failure Peto, Philippa, King’s College Hospital
P10	The Survival of Asian Americans receiving Haemodialysis and Peritoneal Dialysis Treatment in the United States: A longitudinal trend analysis from 1995-2006 Stack, Austin, Health Services Executive
P11	Viruses in the Peritoneum of Patients on Peritoneal Dialysis – An Unknown Quantity Summers, Angela, Central Manchester Foundation Trust
P12	Self- locating peritoneal dialysis catheters – 1 year’s experience Whitehead, Duncan, Royal Devon & Exeter NHS Trust

	Psychosocial (Tuesday 18^th May 12.00-13.00)

P19	Perceptions of modality choice and decision making in older haemodialysis patients: Data from the BOLDE study Johansson, Lina, Imperial College London
P20	A qualitative study of the views and attitudes of patients excluded form the kidney transplant waiting list. Lawrence, Christopher, East and North Herts NHS Trust

	Service Delivery 1 (Tuesday 18^th May 12.00-13.00)

P372	Reducing clostridium difficile rates on a nephrology and transplant ward Aggett, Justine, Cardiff and Vale ULHB
P373	A Single-centre Retrospective Evaluation of the Impact of eGFR Reporting on the Preparation of Patients for Renal Replacement Therapy. Connor, Andrew, Dorset County Hospital
P374	Fed-up of waiting for Connecting for Health? – developing a low-cost computer information sharing system in Greater Manchester Dunlop, Joanna, Salford Royal NHS Foundation Trust
P375	Using experience to gain insights from which to identify opportunities for improvement on a dialysis unit – an ‘experience based design’ (EBD) approach Gregson, Joanne, Salford Royal Foundation Trust
P376	Survey of Global Adequacy of Dialysis and Diabetes Care within a Single Renal Unit Hayat, Amer, Department of Renal Medicine
P377	Unified Haemodialysis procedures in Ireland; The Border holds no Boundaries McManus, Betty, Belfast City Hospital
P378	Developing a Kidney care Specific Trigger Tool to Proactively Identify Adverse Events Ponnusamy, Arvind, Salford Royal NHS Foundation Trust

	Service Delivery 2 (Wednesday 19^th May 12.30-13.30)

P365	The relative risk of commencing renal replacement therapy (RRT) with increasing social deprivation in the UK. Castledine, Clare, UK Renal Registry
P366	Getting the culture right - Moving to a comprehensive system of excellence for vascular access using quality improvement techniques. Gregson, Joanne, Salford Royal Foundation Trust
P367	Haemodialysis Action Learning Set… 2 years on… Hannah, Julie, York Hospital
P368	Using experience to gain insights from which to identify opportunities for improvement on a dialysis unit – an ‘experience based design’ (EBD) approach Nache, Azri, Wigan Renal Unit
P369	Improving a Catheter Safety check list: A way to achieve best practice in safety around line insertion. Ponnusamy, Arvind, Salford Royal NHS Foundation Trust
P370	Demonstrating Performance of a Vascular Access Service with Process Behaviour Charts Rayner, Hugh, Heart of England NHS Foundation Trust
P371	Evaluation of Clinical Molecular Genetic Testing for ADPKD in a Multidisciplinary Clinic Sandford, Richard, University of Cambridge

	Service Delivery 3 (Thursday 20^th May 11.30-12.30)

P358	National study of new models of ESRD care for young adults aimed at improving adherence and patient outcomes Beard, Clare, NHS Kidney Care
P359	A renal nursing course to meet nurses' individual development needs in an NHS Trust hospital. Duncan, Christopher, University Hospitals Birmingham NHS Trust
P360	Enabling patients to have dialysis at home Dunne, Marjorie, Baxter Healthcare Ltd
P361	Using Peer Review to Support Improvement and Quality Assure Implementation of National Renal Guidance. Grant, Nanette, NHS Warwickshire
P362	Nursing documentation should make sense, should have meaning, and should communicate Gregson, Joanne, Salford Royal Foundation Trust
P363	Violence & Aggression: Prevention and management strategies in European Dialysis, Nephrological and Transplantation Units. Johnson, Catherine, ANSA
P364	Are we getting it right? Evaluation of Multi-Centre Living Donor Kidney Programme. Woods, Madeline, Guy's and St Thomas' NHS Foundation Trust

	Transplant (1) (Tuesday 18^th May 12.00-13.00)

P298	ABO incompatible transplantation is not associated with an increased risk of infection Charif, Rawya, Imperial College Kidney and Transplant Institute
P299	ABO incompatible living donor renal transplantation in West London Galliford, Jack, West London Renal and Transplant Centre, Hammersmith Hospital, London
P300	Campath induction and Tacrolimus monotherapy is effective treatment for successful ABO incompatible live donor renal transplantation Galliford, Jack, West London Renal and Transplant Centre, Hammersmith Hospital, London
P301	Rejection after ABO Incompatible Living Donor Renal Transplantation Galliford, Jack, West London Renal and Transplant Centre, Hammersmith Hospital, London
P302	Use of Calcimimetics in the Management of Renal Bone Disease (RBD) after Renal Transplantation. Imran, Muhammad, Royal Liverpool University Hospital NHS Trust
P303	Blood group antibody titres predict the feasibility of ABO incompatible kidney transplantation. Lawrence, Christopher, Imperial Kidney and Transplant Institute
P304	Live donor kidney transplantation across a positive flow crossmatch Lawrence, Christopher, Imperial College Kidney and Transplant Institute

	Transplant (2) (Wednesday 19^th May 12.30-13.30)

P292	Service development - travel advice for renal transplant patients Allen, Jude, Salford Royal NHS Foundation Trust
P293	Urinary tract infections in the renal transplant population Berry, Miriam, Norfolk and Norwich University Hospital
P294	Automated urine flow cytometry is not sensitive for screening for asymptomatic bacteriuria in renal transplant recipients. Day, Clara, Queen Elizabeth Hospital, Birmingham
P295	Recent Cases of Pneumocystis Pneumonia in Renal Transplant Recipients: One Centre’s Experience. Imran, Muhammad, Royal Liverpool University Hospital NHS Trust
P296	Pre-transplant vaccination against chicken pox Jayanti, Anuradha, Manchester Royal Infirmary
P297	An audit of CMV disease post-transplantation. Sampson, Anna, Oxford Kidney Unit

	Transplant (3) (Thursday 20^th May 11.30-12.30)

P286	5 Years of minimalist immunosuppression with Campath induction and Tacrolimus monotherapy without steroids or MMF in renal transplantation Chan, Edmond KaKit, Imperial College Kidney and Transplant Institute
P287	Low Incidence Of NODAT With Alemtuzumab Induction And Tacrolimus Monotherapy Without Steroids And MMF In Renal Transplantation Chan, Edmond KaKit, Imperial College Kidney and Transplant Institute
P288	Steroid Sparing Regimes Are Not Associated With A High Incidence Of Recurrent Disease After Renal Transplantation Chan, Edmond Kakit, Imperial College
P289	10 Years of Steroid Sparing In Renal Transplantation Chan, Edmond Kakit, Imperial College Kidney and Transplant Institute
P290	Secondary hyperparathyroidism and hypercalcaemia after renal transplantation Harrington, Lucy, Newcastle Medical School
P291	Pre-Transplant Inosine Monophosphate Dehydrogenase Activity Is Associated with Mycophenolate Mofetil Dose After Transplantation Shah, Sapna, Barts and the London School of Medicine and Dentis

	Transplant (4) (Tuesday 18^th May 12.00-13.00)

P280	Obesity and New-Onset Diabetes among Renal Transplant Patients Adam, Jennifer, Sunderland Royal Hospital
P281	Ethnicity does not determine outcome 5 years after donor nephrectomy Charif, Rawya, Imperial College Kidney and Transplant Institute
P282	Outcome of Conservative Management of Transplant Renal Artery Stenosis Chinnappa, Shanmugakumar, Sheffield Kidney Institute
P283	The association between post renal transplant serum calcium and graft function: a single centre cohort study Hiemstra, Thomas, University of Cambridge
P284	Inosine Monophosphate Dehydrogenase (IMPDH) Polymorphisms and Graft Outcome in Renal Transplantation Shah, Sapna, Barts and the London School of Medicine and Dentistry
P285	Optimal management of patients with a history of ANCA associated vasculitis considered for renal transplantation - an ongoing debate! Uniacke, Mark, Portsmouth Hospitals NHS Trust

	Transplant (5) (Wednesday 19^th May 12.30-13.30)

P274	Is statin use associated with reduced incidence of rejection in renal transplant recipients? A study from Nottingham Renal and Transplant Unit Byrne, Catherine, Nottingham University Hospitals Trust
P275	Encapsulating Sclerosing Peritonitis is an important cause of Death after RenalTransplantation. Galliford, Jack, West London Renal and Transplant Centre, Hammersmith Hospital, London
P276	Use of Control Charts and Linear Regression Analysis to allow Earlier Recognition of Renal Transplant dysfunction Parry, Rob, Royal Cornwall Hospital Trust
P277	Transplant nephrectomy following graft failure: who gets it and does it make a difference? Thomson, Peter, Western Infirmary, Glasgow
P278	Recurrence of Complement Factor H-related Protein 5 (CFHR5) Nephropathy in a Renal Transplant Vernon, Katherine, Imperial College London
P279	Donor specific antibody titres predict antibody mediated rejection and response to treatment Willicombe, Michelle, Imperial College Kidney and Transplant Institute

	Transplant (6) (Thursday 20^th May 11.30-12.30)

P269	Vitamin D levels in a multi-ethnic, renal transplant population - all is not equal. Dreyer, Gavin, Barts and the London NHS trust
P270	1 Organ Donation In Black And Minority Ethnic Communities: Using Peer Educators To Access Hitherto “Hard-To-Reach” Populations. Jain, Neerja, Kidney Research UK
P271	Successful living-related renal transplantation in a child with a Fontan circulation Marks, Stephen, University College London
P272	Effect of Peri Operative Blood Transfusion on long term Renal Graft Outcome O' Brien, Frank, Beaumont Hospital
P273	A review clinic for long term renal transplant patients Sayer, John, Newcastle University

	Science Abstract Posters 2010

	Acute Renal Failure (Moderated Session – Tuesday 18^th May 12.00-13.00

P212	Reduction of paraquat-induced renal dysfunction in rats by a manganese complex of ethylenebis(hydroxyphenylglycine) (EHPG) Chatterjee, Prabal, University of Brighton
P213	Involvement of IgM Natural Antibodies in Renal Ischaemia Reperfusion Injury: a potential new therapeutic target? Ferenbach, David, University of Edinburgh
P214	Erythropoietin (EPO) protects the kidney against the injury and dysfunction caused by ischaemia-reperfusion (I/R) in diabetic rats. Kieswich, Julius , Centre for Translational Medicine and Therapeutics
P215	Thiamine protects the kidney against the injury and dysfunction caused by ischaemia reperfusion by multiple mechanisms. Memon, Shoab A, CTMT, William Harvey Research Institute
P216	Prevention of Post-Cardiopulmonary Bypass Acute Kidney Injury and Endothelial Dysfunction using Sitaxsentan sodium, an Endothelin-A Receptor Antagonist Patel, Nishith,University of Bristol
P217	Interactions Between Allogenic Red Cell Transfusion and Cardiopulmonary Bypass In Post Cardiac Surgery Acute Kidney Injury Patel, Nishith, University of Bristol

	Cell Biology (Thursday 20^th May 11.30-12.30)

P224	The LIM protein, Hic-5, Regulates an Extracellular Matrix-derived TGF-ß-independent Pro-sclerotic Feedback Loop in Mesangial Cells, in vitro and in Experimental Diabetic Glomerulosclerosis Hornigold, Nick, University of Leeds
P225	Phenotypic and functional plasticity of macrophages and dendritic cells in vitro and mononuclear phagocyte phenotype in vivo. Mylonas, Katie, University of Edinburgh
P226	SRp40 mediates TGFß1-induced post-transcriptional splicing of Fibronectin in renal epithelial cells Phanish, Mysore, SWT Institute for Renal Research
P227	Inducing Differentiation of Human Metanephric Mesenchyme Price, Karen, Nephro-Urology Unit, UCL Institute of Child Health
P228	Establishment of conditionally immortalised human glomerular mesangial cells in culture Sarrab, Ramadan, University of Bristol
P229	Antiapoptotic role of cadmium in human renal proximal tubule cells Shah, Nilesh, South West Thames Institute for Renal Research
P230	Differential expression and regulation of cadherins in human renal tubule epithelial cells Shah, Nilesh, South West Thames Institute for Renal Research

	Complement & Endothelial Biology (Wednesday 19^th May 12.30-13.30)

P83	ABO Antibodies with Synthetic Blood Group Trisaccharides using Surface Plasmon Resonance – Rapid and Specific Assessment. Bentall, Andrew, University Hospital, Birmingham
P84	Treatment of Endothelial Cells with Serine Proteases induces Exocytosis of Weibel-Palade Bodies Bevins, Anne, University of Birmingham
P85	Factor I autoantibodies are associated with atypical haemolytic uraemic syndrome Kavanagh, David, Institute of Human Genetics
P86	Inhibition of ANCA-Induced Neutrophil Degranulation and vWF release by Simvastatin Little, Mark, Centre for Nephrology, UCL
P87	Factor H autoantibodies are associated with MPGN Marchbank, Kevin, Newcastle University
P88	The Co-ordinated Role of Podocytes and Glomerular Endothelial Cells in Glomerular Inflammation Panchagnula, Sahithi, University of Birmingham
P89	Neutrophil-derived serine proteases activate endothelial cells, independently of PAR activation Tull, Samantha, University of Birmingham

	Endothelial & Vascular Biology (Wednesday 19^th May 12.30-13.30)

P218	The selective P2X7 receptor antagonist A438079 ameliorates vascular smooth muscle cell calcification in vitro. Booth, John WR, University College London
P219	Novel Methods for the Identification of Circulating Microparticles in Patients with Chronic Kidney Disease Burton, James, John Walls Renal Unit, Leicester
P220	In vitro stimulation of glomerular endothelial cells results in complement factor synthesis Hamer, Rizwan, University Hospitals Coventry and Warwickshire, NHS Trust
P221	Long-term mechanical strain of human vascular smooth muscle cells maintains contractile phenotype, inhibits alkaline phosphatase and Osteocalcin production and prevents calcification Molostvov, Guerman, Warwick Medical School
P222	Rosiglitazone restores a nitric oxide mediated defect in vasorelaxation in Pkd2 mesenteric arterioles Ong, Albert, University of Sheffield
P223	Comparison of the effects of manumycin A and FTI-277 on vascular calcification Ponnusamy, Arvind, University of Manchester

	Fibrosis (1) (Wednesday 19^th May 12.30-13.30)

P97	The Effects of a Thrombin Activatible Fibrinolysis Inhibitor (TAFI) Inhibitor on Plasmin Activity Atkinson, John, University of Sheffield
P98	Gadoterate, a macrocyclic MRI contrast agent, does not induce nephrogenic systemic fibrosis in a rat model of renal failure Haylor, John, University of Sheffield
P99	Modified Citrus Pectin –Protective Effects in Experimental Nephropathy Kolatsi-Joannou, Maria, Nephro-Urology Unit, UCL
P100	Seliciclib does not improve renal fibrosis in the rat following sub-total nephrectomy. Nutter, Faith, Sheffield Kidney Institute
P101	Renal fibroblasts that are linked to albumninuria and tubulointerstitial damage in IgA nephropathy are defined by CD248 Smith, Stuart William, University of Birmingham
P102	C-Terminal CTGF Fragment Binds to and Modulates BMP-7 Signaling. Winn, Simon, SW Thames Institute for Renal Research

	Fibrosis (2) (Thursday 20^th May 11.30-12.30)

P90	Can the individual domains of TG2 be produced as recombinant proteins in E.Coli in a form that will provide an immunogenic response in mice? Ben Ayad, Osama, The University of Sheffield
P91	The Human Hyaluronan Synthase 2 Gene and its Natural Antisense RNA Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell Bowen, Timothy, Cardiff University
P92	A crucial sequence for tissue transglutaminase transport in its N-terminal ß-sandwich domain Chou, Che-Yi, University of Sheffield
P93	All-trans retinoic acid is pro-fibrotic in a normal rat kidney fibroblast cell line: a role for lipid-binding proteins and retinoid nuclear receptors? Rankin, Alexandra, King's College London
P94	Differential control of fibroblast hyaluronan synthase 2 and intercellular adhesion molecule 1 expression induced by monocytes. Steadman, Robert, University of Cardiff
P95	Epithelial-Mesenchymal Transition of Proximal tubular epithelial cells: the role of TSG-6. Steadman, Robert, University of Cardiff
P96	Monocytes induce hyaluronan synthase 2 and intercellular adhesion molecule 1 in fibroblasts. Steadman, Robert, University of Cardiff

	Genetic Renal Disease (1) (Moderated Session – Tuesday 18^th May 12.00-13.00)

P200	Development of a novel murine model of nephronophthisis Eley, Lorraine, Newcastle University
P201	URAT1 polymorphisms in hypouricaemic patients Hynes, Ann Marie, Newcastle University
P202	Hereditary late onset FSGS can develop in patients with familial microscopic haematuria due to heterozycous COL4A3/COL4A4 mutations on top of thin glomerular basement membranes - this is the explanation for Autosomal Dominant Alport. Results from 170 patients with four different mutations in 17 large Cypriot family pedigrees Pierides, Alkis, Hippocrateon Hospita, Nicosia, Cyprus
P203	AHI1 and CC2D2A genetically interact - zebrafish models of nephronophthisis and Joubert Sydrome Simms, Roslyn, Institute of Human Genetics
P204	Congenital cystic kidney disease - Increasingthe recognition of HNF1ß mutations Simms, Roslyn, Institute of Human Genetics
P205	Identification, Characterisation and Functional Analysis of a Novel Polycystin-2 Phosphorylation Site Streets, Andrew, Sheffield Kidney Institute

	Genetic Renal Disease (2) (Wednesday 19^th May 12.30-13.30)

P206	A novel hybrid complement gene associated with familial haemolytic uraemic syndrome Goodship, Tim, Newcastle University
P207	Somatic PKD1 mutations and mutant polycystin-1 expression in human PKD1 cystic cells Huang, Linghong, The University of Sheffield
P208	Renal fibromuscular dysplasia is unlikely to be familial and is not caused by smooth Muscle a alpha actin mutations. Marks, Stephen, University College,London
P209	Role of Epithelial to Mesenchymal Transdifferentiation (EMT) in disease progression in Autosomal Dominant Polycystic Kidney Disease. Norman, Jill, UCL
P210	The clinical characteristics of familial mesangial c3 only glomerulonephritis due to duplication of exons 2&3 of CFHR5 - A new entity. Clinical data on 100 patients from 16 Cypriot family pedigrees Pierides, Alkis, Hippocrateon Hospital, Nicosia, Cyprus
P211	A recurrent UMOD mutation causes late-onset autosomal dominant end-stage renal failure. Smith, Graham, Cambridge University

	Immunological Renal Disease (1) (Moderated Session – Tuesday 18^th May 12.00-13.00)

P71	Functional observations on the Dark Agoutito Wistar Furth rat model of chronic renal aloograft injury Butt, Imran, Sheffield University
P72	IL-17-/- mice are protected from nephrotoxic nephritis and are resistant to disease induction by adoptive cell transfer Hamour, Sally, Imperial College London
P73	Direct effect of Spleen tyrosine kinase (Syk) inhibition on the glomerular cytokine network McAdoo, Stephen, Imperial College London
P74	Effect of anti-IL6 monoclonal antibody therapy in the treatment of established experimental autoimmune glomerulonephritis in the CD1 mouse Reynolds, John, Imperial College, London
P75	Macrophage activation and function in the pathogenesis of experimental autoimmune glomerulonephritis Reynolds, John, Imperial College London
P76	Molecular Mimicry of ERV-3 virus and Autoantigens in SLE: a mechanism for disease Rylance, Paul, Renal Unit, Royal Wolverhampton Hospitals, New Cross Hospital,Wolverhampton

	Immunological Renal Disease (2) (Thursday 20^th May 11.30-12.30)

P77	T-type calcium channel inhibition reduces glomerular injury and serum creatinine in chronic mesangial proliferative glomerulonephritis in rats Cove-Smith, Andrea, Kings College London
P78	Proliferation and Activation during Tubulointerstitial Injury in the Native Kidney Ingham, V.J, Newcastle University
P79	CD28null T-helper cell expansion in Wegener’s granulomatosis is driven by Cytomegalovirus and increases the risk of infection and more severe renal disease Morgan, Matthew, University of Birmingham
P80	Quantitative measurement of natural killer (NK) cell function in early and late renal transplant patients Morteau, Olivier, Wellcome Trust Centre for Human Genetics
P81	Renal Expression Of Complement Factor H (CFH) And Factor H-related Proteins (CFHRs) Vernon, Katherine, Imperial College, London
P82	Copy number, linkage disequilibrium and disease association in the FCGR locus Willcocks, Lisa, Cambridge Institute for Medical Research

	Miscellaneous (1) (Wednesday 19^th May 12.30-13.30)

P65	The acidosis-sensing amino acid transporter SNAT2 regulates the anabolic kinase mTOR in skeletal muscle cells through SNAT2’s substrate L-Methionine (L-Met) Bevington, Alan, University of Leicester
P66	CCL15 in peritoneal dialysate - the West London Prospective PD Study Goodlad, Catriona, Imperial College Kidney and Transplant Institute
P67	Genome-wide identification of hypoxia inducible factor transcriptional targets in renal cancer Mole, David, The Welcome Trust Centre for Human Genetics
P68	Role of Inosine monophosphate dehydrogenase (IMPDH) activity in erythropoiesis: Potential mechanism of Mycophenolic Acid (MPS) induced anaemia Pile, Taryn, Queen Mary University, London
P69	Lymphangiogenesis in Renal Inflammation– a novel role for Tonicity Responsive Enhancer Binding Protein Vass, David, University of Edinburgh
P70	Retinoic acid signaling in the collecting duct system of postnatal mouse kidney Wong, Yuen Fei, King's College, London

	Miscellaneous (2) (Thursday 20^th May 11.30-12.30)

P58	A novel model of metabolic syndrome and Insulin resistance in experimental uraemia in rats and the effect of inhibition of the enzyme 11 beta hydroxyl-steroid dehydrogenase type 1 (11HSD1). Chapagain, Ananda, William Harvey Research Institute
P59	ANCA stimulated neutrophils release BLyS and promote B cell survival in vitro Holden, Neil, University of Birmingham
P60	Insulin Resistance in ESRD Kazempour-Ardebili, Sara, Imperial College, London
P61	Role of Hypoxia Inducible Factor (HIF) in the Regulation of Hepcidin by Oxygen and Iron. Mole, David, Welcome Trust Centre for Human Genetics
P62	Immune profile and Epstein-Barr virus (EBV) infection in acute interstitial nephritis: an immunohistochemical study in 78 patients Oh, Weng, Renal Institute of Birmingham
P63	Modulating the Adhesion of Hematopoietic Stem Cells to Ischemia-Reperfusion (IR) Injured Kidney Sections and Identification of the Molecular Mechanisms Governing their Adhesion. White, Rebecca, Kalia Group
P64	The Renal Genome Ontology Annotation (GOA) Initiative Alam-Faruque, Yasmin, The Wellcome Trust Genome Campus

	Podocyte Biology (Moderated Session – Tuesday 18^th May 12.00-13.00)

P231	The contribution of the glycosaminoglycans hyaluronic acid and chondroitin sulphate to the glomerular endothelial cell glycocalyx in vitro Armstrong, Lynne, University of Bristol
P232	Autocrine regulation of the Insulin like growth factors are critical for podocyte survival and glomerular function of the kidney. Hale, Lorna, University of Bristol
P233	Endothelin-1 stimulates podocyte endothelin-1 & pro-inflammatory cytokine production & causes cytoskeletal re-arrangement Owen, Elizabeth, Queens Medical Research Institute, University of Edinburgh
P234	Reactive Oxygen Species modulate barrier function of the human glomerular endothelial glycocalyx Singh, Anurag, University of Bristol
P235	Podocyte Notch signaling causes impaired murine glomerular filtration barrier function and decreased slit diaphragm protein expression. Waters, Aoife, Institute of Child Health, London

	Tubular Epithelial Cell Biology (Thursday 20^th May 11.30-12.30)

P236	Determination of Constitutive and Agonist Stimulated Phospho-Acceptor Sites in the Cytoplasmic Tail of Megalin. Baines, Richard, Department of Infection, Immunity and Inflammation
P237	CD36 is a Novel High Capacity Receptor for Albumin in Proximal Tubular Cells. Baines, Richard, Department of Infection, Immunity and Inflammation
P238	Myeloma Light Chains Activate Tubular Epithelial Cells By A C-Src Mediated Redox Signaling Mechanism. Basnayake, Kolitha, University of Birmingham
P239	Differential Progression Of Renal Scarring And Determinants Of Late Renal Recovery In Sustained Dialysis Dependent Acute Kidney Injury Secondary To Myeloma Kidney. Basnayake, Kolitha, University of Birmingham
P240	An Assessment Of The Pathogenicity Of Polyclonal Immunoglobulin Free Light Chains In Chronic Kidney Disease. Basnayake, Kolitha, University of Birmingham
P241	Transepithelial Resistance (TER) changes in a proximal tubular cell line as a sensitive predictor of drug-induced nephrotoxicity Othman, Nurul H, University of Aberdeen

	Urinary Proteomics (Moderated Session – Tuesday 18^th May 12.00-13.00)

P53	Urinary e- γ (glutamyl) lysine: A novel biomarker of Chronic Kidney Disease. Da Silva Lodge, Michelle, University of Sheffield
P54	An early pregnancy urinary proteomic fingerprint accurately predicts later pre-eclampsia Hall, Matt, Leicester General Hospital
P55	Robust List of Human Urinary Exosomal Proteins Identified by LC-MS/MS Hiemstra, Thomas F, University of Cambridge
P56	A Novel Approach to Urine Mass Spectrometry without Abundant Protein Depletion Using a Uromodulin Exclusion List Hiemstra, Thomas F, University of Cambridge
P57	Development of sample preparation methods in serum and urine proteomics for application to early complications after renal transplantation Welberry Smith, Matthew, St James University Hospital

Site Map